In the new ear of MS drugs, safety has been an important consideration. The risk of cancer in patients treated with IFNs has been raised, although never proven. In this issue of JNNP, a large study from British Columbia categoricaly excludes the association of any cancers with MS. Interestingly, there was a non-signifcant increase in the risk of breast cancer, most likely a chance occurence.
Must read more at: http://jnnp.bmj.com/content/85/10/1096.abstract
J Neurol Neurosurg Psychiatry 2014;85:1096-1102 doi:10.1136/jnnp-2013-307238
- Multiple sclerosis
- Research paper
Assessment of cancer risk with β-interferon treatment for multiple sclerosis
(Visited 114 times, 1 visits today)